Analysis finds variable outcomes of alpha1-antitrypsin deficiency in liver disease among children, indicating complex implications.
Among 424 children with liver disease, 20 had α1-antitrypsin deficiency associated with protease inhibitor ZZ phenotype. The disorder manifested itself as cholestasis in early infancy in 19 children. Jaundice and pruritus cleared in 16 of these by 7 months of age, but hepatomegaly and laboratory evidence of mild hepatic dysfunction persisted in all. Biliary cirrhosis and portal hypertension eventually developed or was suspected in eight, and hypoplasia of intrahepatic bile ducts was demonstrated in another four. Routine screening revealed intermediate α1-antitrypsin deficiency in 16 other children with various types of liver disease. The phenotype in these patients was MZ, MS, or SZ. PAS-positive granules were present in liver of all patients with the ZZ phenotype and in none with other phenotypes. The findings indicate that manifestations and prognosis of this inherited liver disease are extremely variable.
No takes yet. Share an insight, caveat, or question.
Odièvre et al. (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: